150 related articles for article (PubMed ID: 26893558)
1. Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene.
Luo L; Du T; Zhang J; Zhao W; Cheng H; Yang Y; Wu Y; Wang C; Men K; Gou M
Int J Nanomedicine; 2016; 11():501-12. PubMed ID: 26893558
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A.
Zhang L; Gao X; Men K; Wang B; Zhang S; Qiu J; Huang M; Gou M; Huang N; Qian Z; Zhao X; Wei Y
Int J Nanomedicine; 2011; 6():2419-27. PubMed ID: 22072877
[TBL] [Abstract][Full Text] [Related]
3. Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.
Yang F; Gou M; Deng H; Yi T; Zhong Q; Wei Y; Zhao X
Oncol Rep; 2012 Aug; 28(2):668-76. PubMed ID: 22684947
[TBL] [Abstract][Full Text] [Related]
4. Efficient Inhibition of Ovarian Cancer by Gelonin Toxin Gene Delivered by Biodegradable Cationic Heparin-polyethyleneimine Nanogels.
Bai Y; Gou M; Yi T; Yang L; Liu L; Lin X; Su D; Wei Y; Zhao X
Int J Med Sci; 2015; 12(5):397-406. PubMed ID: 26005374
[TBL] [Abstract][Full Text] [Related]
5. Efficient inhibition of an intraperitoneal xenograft model of human ovarian cancer by HSulf-1 gene delivered by biodegradable cationic heparin-polyethyleneimine nanogels.
Liu P; Gou M; Yi T; Xie C; Qi X; Zhou S; Deng H; Wei Y; Zhao X
Oncol Rep; 2012 Feb; 27(2):363-70. PubMed ID: 22086394
[TBL] [Abstract][Full Text] [Related]
6. Self-Assembled Nanoparticle Mediated
Xiao Y; Wang C; Xiong M; Yang Y; Zhang Q; Liu X; Zou B; Gou M
J Biomed Nanotechnol; 2018 Dec; 14(12):2092-2101. PubMed ID: 30305216
[TBL] [Abstract][Full Text] [Related]
7. Efficient inhibition of ovarian cancer by truncation mutant of FILIP1L gene delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.
Xie C; Gou ML; Yi T; Deng H; Li ZY; Liu P; Qi XR; He X; Wei Y; Zhao X
Hum Gene Ther; 2011 Nov; 22(11):1413-22. PubMed ID: 21513424
[TBL] [Abstract][Full Text] [Related]
8. The enhanced antitumor effects of biodegradable cationic heparin-polyethyleneimine nanogels delivering HSulf-1 gene combined with cisplatin on ovarian cancer.
Liu P; Gou M; Yi T; Qi X; Xie C; Zhou S; Deng H; Wei Y; Zhao X
Int J Oncol; 2012 Oct; 41(4):1504-12. PubMed ID: 22825572
[TBL] [Abstract][Full Text] [Related]
9. [Preparation of recombinant HIV-TATm-survivin (T34A) protein and its pro-apoptosis activity to cancer cells in vitro].
Zheng WY; Ma XY; Wei DZ; Wang JZ; Liu QH; Ma YS; Yang SL
Sheng Wu Gong Cheng Xue Bao; 2006 Mar; 22(2):285-92. PubMed ID: 16607958
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of heparin-polyethyleneimine nanogels delivering claudin-3-targeted short hairpin RNA combined with low-dose cisplatin on ovarian cancer.
Liu L; Gou M; Yi T; Bai Y; Wei Y; Zhao X
Oncol Rep; 2014 Apr; 31(4):1623-8. PubMed ID: 24482188
[TBL] [Abstract][Full Text] [Related]
11. High-level expression, purification and pro-apoptosis activity of HIV-TAT-survivin (T34A) mutant to cancer cells in vitro.
Ma X; Zheng W; Wei D; Ma Y; Wang T; Wang J; Liu Q; Yang S
J Biotechnol; 2006 May; 123(3):367-78. PubMed ID: 16406157
[TBL] [Abstract][Full Text] [Related]
12. Construction, expression, and purification of HIV-TAT-survivin (T34A) mutant: a pro-apoptosis protein in Escherichia coli.
Ma X; Zheng W; Wei D; Ma Y; Wang T; Wang J; Liu Q; Yang S
Protein Expr Purif; 2006 May; 47(1):36-44. PubMed ID: 16260148
[TBL] [Abstract][Full Text] [Related]
13. Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy.
McKay TR; Bell S; Tenev T; Stoll V; Lopes R; Lemoine NR; McNeish IA
Oncogene; 2003 Jun; 22(23):3539-47. PubMed ID: 12789262
[TBL] [Abstract][Full Text] [Related]
14. Local and systemic delivery of mRNA encoding survivin-T34A by lipoplex for efficient colon cancer gene therapy.
Zhang X; Men K; Zhang Y; Zhang R; Yang L; Duan X
Int J Nanomedicine; 2019; 14():2733-2751. PubMed ID: 31118608
[No Abstract] [Full Text] [Related]
15. [Anti-prostate cancer activity of Survivin-T34A mutant in vitro and in vivo].
Pan L; Peng XC; Yuan QZ; Leng F; Yu DD; Shan Y; Li ZY; Wang CT
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 May; 41(3):390-3. PubMed ID: 20629305
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral vectors modified by heparin-polyethyleneimine nanogels enhance targeting to the lung and show therapeutic potential for pulmonary metastasis in vivo.
Wei W; Mu Y; Li X; Gou M; Zhang H; Luo S; Men K; Mao Y; Qian Z; Yang L
J Biomed Nanotechnol; 2011 Dec; 7(6):768-75. PubMed ID: 22416575
[TBL] [Abstract][Full Text] [Related]
17. [Influence of human epithelial ovarian cancer HO-8910 cells with modified survivin gene on the cell cycle distribution and chemosensitivity].
Peng LP; Huang JM; Zhang GN; Zha X; Ren Y; Fan Y; Deng BF
Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):860-4. PubMed ID: 21211287
[TBL] [Abstract][Full Text] [Related]
18. Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-->Ala mutant.
Peng XC; Yang L; Yang LP; Mao YQ; Yang HS; Liu JY; Zhang DM; Chen LJ; Wei YQ
J Exp Clin Cancer Res; 2008 Sep; 27(1):46. PubMed ID: 18816410
[TBL] [Abstract][Full Text] [Related]
19. Antitumoral efficacy by systemic delivery of heparin conjugated polyethylenimine-plasmid interleukin-15 complexes in murine models of lung metastasis.
Zhou X; Li X; Gou M; Qiu J; Li J; Yu C; Zhang Y; Zhang N; Teng X; Chen Z; Luo C; Wang Z; Liu X; Shen G; Yang L; Qian Z; Wei Y; Li J
Cancer Sci; 2011 Jul; 102(7):1403-9. PubMed ID: 21564417
[TBL] [Abstract][Full Text] [Related]
20. Genetic protein TmSm(T34A) enhances sensitivity of chemotherapy to breast cancer cell lines as a synergistic drug to doxorubicin.
Xu Y; Zheng W; Wang T; Wang P; Zhu L; Ma X
Biomed Pharmacother; 2012 Jul; 66(5):368-72. PubMed ID: 22560635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
